Pierzyński P

No ORCID on file · 7 papers in corpus · active 2006-2025

Study types

  • article 4
  • other 1

Condition tags

  • endometriosis 5
  • infertility 3
  • dysmenorrhea 1
article 2025
Diagnostics ·doi:10.3390/diagnostics15111366

Background: Endometriosis is a common gynecological disease linked to significant diagnostic challenges. Cadherin 12 (CDH12), as a member of adhesion molecules, is supposed to be involved in the pathogenesis of this disease and therefore ca…

2025
BMC women's health ·doi:10.1186/s12905-024-03531-z

BackgroundEmbryo implantation involves two key elements: a good quality embryo and receptive endometrium. Endometrial receptivity abnormalities are known as one of the possible causes of recurrent implantation failure (RIF), especially when…

article 2024
Frontiers in endocrinology ·doi:10.3389/fendo.2024.1359182

BACKGROUND: The aim of this study was to analyze the concentration of leptin in peritoneal fluid and plasma and to assess their role as potential biomarkers in the diagnosis of endometriosis. MATERIALS & METHODS: Leptin adjusted for BMI (l…

article 2024
Advances in medical sciences ·doi:10.1016/j.advms.2024.04.004

PURPOSE: Endometriosis is a common disease with a complex pathomechanism and atypical symptoms, often leading to delayed diagnosis. Currently, the sole method for confirming the presence of the disease is through laparoscopy and histopathol…

article 2023
International journal of molecular sciences ·doi:10.3390/ijms241814363

Endometriosis is a chronic disease in which the endometrium cells are located outside the uterine cavity. The aim of this study was to evaluate circulating 20S proteasome and 20S immunoproteasome levels in plasma and peritoneal fluid in wom…

2021
Journal of clinical medicine ·doi:10.3390/jcm10245945

Bisphenol A (BPA), the most common endocrine-disrupting chemical, has been associated with male reproductive dysfunctions. Recently, it has been shown that BPA may also affect miRNAs expression. Herein, we aimed to evaluate the association …

other 2006
Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology ·doi:10.1080/09513590601030233

Current treatment of painful periods and other symptoms related to primary dysmenorrhea (PD) is usually commenced with non-steroidal anti-inflammatory drugs or oral contraceptives, which fails in about 10% of affected patients. Tamoxifen, a…